Organometallics
Article
cooled to −78 °C. An ethereal solution of hexylmagnesium bromide
(13.5 mL, 26.3 mmol) cooled to −78 °C was added to the Schlenk
flask dropwise with stirring over 20 min via cannula while maintaining
the temperature. The mixture was then allowed to warm slowly to
ambient temperature over 18 h. Degassed water (∼10 mL) was added
slowly to quench any remaining hexylmagnesium bromide. The
ethereal layer was then transferred via cannula to a Schlenk flask
containing sodium sulfate and equipped with a sintered glass filter and
second Schlenk flask. The sodium sulfate was filtered, and the solids
were washed with additional Et2O. The Et2O was then removed in
vacuo, and the crude product was transferred via cannula to a
distillation setup. The product was distilled under vacuum (45 °C, 0.5
mmHg) to yield the title compound as a colorless oil (1.07 g, 40%).
1H NMR (C6D6, 400 MHz): δ 1.59 (m, 2H), 1.52 (m, 2H), 1.38 (m,
2H), 1.28 (m, 6H), 1.08 (d, J = 7.1 Hz, 3H), 1.05 (d, J = 6.6 Hz, 3H),
1.03 (d, J = 6.6 Hz), 1.01 (d, J = 7.1 Hz), 0.89 (m, 3H). 13C{1H} NMR
(C6D6, 125 MHz): δ 32.0, 31.7 (d, J = 11.6 Hz), 28.7 (d, J13C‑31P = 18.8
Hz), 23.9, 23.8, 23.1, 22.3 (d, J13C‑31P = 19 Hz), 20.5, 20.34, 19.1, 19.0,
14.3. 31P NMR (CD2Cl2, 160 MHz): δ 3.08. HRMS(ESI): calcd for
[M + H]+ 203.1923, found 203.1930.
[Cp*Ir(Ph2P{heptanoyl})Cl2] (6). To a stirring suspension of
[Cp*IrCl2]2 (200 mg, 0.251 mmol) in THF (5 mL) was added 1 (160
mg, 0.536 mmol). The mixture was stirred at ambient temperature for
2 h, and the solvent was then removed under vacuum. The residue was
dissolved in Et2O and cooled to −30 °C to yield 6 as an orange
crystalline solid (315 mg, 90%). 1H NMR (CD2Cl2, 400 MHz): δ 7.60
(t, J = 8.6 Hz, 4H), 7.49 (m, 6H), 2.84 (m, 2H), 1.39 (m, 2H), 1.36 (d,
J1H‑31P = 2.2 Hz, 15H), 1.17 (m, 2H), 1.09 (m, 4H), 0.79 (t, J = 7.2 Hz,
3H). 13C{1H} NMR (CD2Cl2, 100 MHz): δ 213.3 (d, J13C‑31P = 14.9
Hz), 135.5 (d, J13C‑31P = 8.9 Hz), 131.5 (d, J13C‑31P = 2.0 Hz), 128.6 (d,
J13C‑31P = 11 Hz), 128.1, (d, J13C‑31P = 49.0 Hz), 93.3 (d, J13C‑31P = 2.0
Hz), 46.6 (d, J13C‑31P = 39.3 Hz), 31.9, 28.9, 23.6 (d, J13C‑31P = 2 Hz),
22.2, 14.1, 8.4. 31P NMR (CD2Cl2, 160 MHz): δ 23.1. IR (cm−1) 1699
(CO). HRMS(ESI): calcd for [M − Cl]+ 661.1965, found 661.1940.
Anal. Calcd for C29H38Cl2IrOP: C, 49.99; H, 5.50. Found: C, 49.69; H,
5.29.
washed with cold pentane to yield 9 as an orange powder (284 mg,
99%). H NMR (CD2Cl2, 400 MHz): δ 3.01 (m, 2H), 2.95 (m, 2H),
1
1.57 (m, 2H), 1.48 (d, J1H‑31P = 1.6 Hz, 15H), 1.47 (m, 6H), 1.36 (d, J
= 7.2 Hz, 3H), 1.33 (d, J = Hz, 3 H), 1.26 (m, 24H), 0.87 (t, J = 6.8
Hz, 3H). 13C{1H} NMR (CD2Cl2, 100 MHz): δ 216.3 (d, J13C‑31P
=
12.7 Hz), 91.9 (d, J13C‑31P = 2.4 Hz), 44.5 (d, J13C‑31P = 31.6 Hz), 32.0,
29.6, 29.5, 29.5, 29.4, 29.3, 29.0, 26.1 (d, J13C‑31P = 24 Hz), 26.0, 22.6.
22.4, 21.3, 21.2, 19.7, 13.8, 8.0. 31P NMR (CD2Cl2, 160 MHz): δ 24.6.
IR (cm−1): 1670 (CO). HRMS(ESI): calcd for [M − 2Cl + H]+
685.4085, found 685.4046. Anal. Calcd for C32H60Cl2IrOP: C, 50.91;
H, 8.01. Found: C, 51.02; H, 7.86.
[Cp*Ir(iPr2P{hexyl})Cl2]. To a stirring suspension of [Cp*IrCl2]2
(200 mg, 0.25 mmol) in THF (5 mL) was added hexyldiisopropyl-
phosphine (110 mg, 0.54 mmol). The mixture was stirred at ambient
temperature for 2 h, and the solvent was then removed under vacuum.
The residue was washed with cold pentane to yield the title compound
1
as an orange powder (260 mg, 86%). H NMR (C6D6, 400 MHz): δ
2.47 (m, 2H), 2.40 (m, 2H), 1.65 (m, 2H), 1.35 (d, J1H‑31P = 1.6 Hz,
15H), 1.27 (m, 6H), 1.20 (d, J = 7.1 Hz, 3H), 1.17 (d, J = 7.3 Hz, 3H),
1.15 (d, J = 7.4 Hz, 3H), 1.11 (d, J = 7.2 Hz, 3H), 0.87 (t, J = 6.9 Hz,
3H). 13C{1H} NMR (C6D6, 100 MHz): δ 92.2 (d, J13C‑31P = 2.4 Hz),
32.0 (d, J13C‑31P = 12.5 Hz), 25.9 (d, J13C‑31P = 35.5 Hz), 25.3, 25.2,
23.1, 20.7 (d, J13C‑31P = 37.4 Hz), 19.5, 19.4, 19.2, 14.3, 9.4. 31P NMR
(CD2Cl2, 160 MHz): δ 3.08. HRMS(ESI): calcd for [M − 2Cl + H]+
531.2727, found 531.2725. Anal. Calcd for C22H42Cl2IrP: C, 43.99; H,
7.05. Found: C, 44.00; H, 6.95.
[Cp*Ir(iPr2P{(Z)-1-(diisopropylphosphino)hept-3-en-1-one})-
H]PF6 (12). Silver hexafluorophosphate (42 mg, 0.17 mmol) and 8
(50 mg, 0.78 mmol) were combined in CH2Cl2 (1 mL) and stirred at
40 °C for 4 h. The mixture was then cooled to ambient temperature
and filtered through a pad of Celite. The resulting solution was
concentrated to ∼0.5 mL, and pentane was added to precipitate a
white powder, which was collected by vacuum filtration and dried in
vacuo to yield 12 (36 mg, 66%). 1H NMR (CDCl3, 400 MHz): δ 3.42
(t, J = 8.4 Hz, 1H, CHCH), 3.12 (m, 1H, CHCH), 2.85 (dd, J =
19.6 Hz, J = 8.8 Hz, 1H, αCH2), 2.46 (q, J = 6.8 Hz, 2H, iPrCH), 2.05
(s, 15H), 2.05 (m, 1H, αCH2), 1.80 (m, 1H, δCH2), 1.48 (m, 2H),
1.23 (m, 6H), 1.00 (m, 3H), 0.99 (m, 3H), 0.90 (m, 3H), 0.58 (m,
3H), −17.21, (d, J1H‑31P = 32 Hz, 1H). 13C{1H} NMR (CDCl3, 100
MHz): δ 225.7 (d, J13C‑31P = 16.8 Hz), 101.2, 58.5 (CHCH), 42.5
(CHCH), 40.4 (d, J13C‑31P = 48.3 Hz, αCH2), 36.5, 24.7, 23.4 (d,
J13C‑31P = 21.2 Hz), 22.6 (d, J13C‑31P = 35.7 Hz), 18.7, 18.1, 16.6, 16.5,
13.8, 9.9. 31P NMR (CDCl3, 160 MHz): δ 72.3 (d, J31P‑1H = 2.9 Hz),
143.8 (sept, J31P‑19F = 713 Hz). 19F NMR (CDCl3, 376 MHz): δ −73.3
(d, J19F‑31P = 711 Hz). IR (cm−1): 2182 (Ir−H), 1700 (CO).
HRMS(ESI): calcd for [M − 2Cl + H]+ 557.2520, found 557.2527.
Anal. Calcd for C24H41F3IrO4PS: C, 40.84; H, 5.85. Found: C, 40.65;
H, 5.65.
[Cp*Ir(Cy2P{heptanoyl})Cl2] (7). To a stirring suspension of
[Cp*IrCl2]2 (100 mg, 0.125 mmol) in THF (5 mL) was added 2 (82
mg, 0.264 mmol). The mixture was stirred at ambient temperature for
2 h, and the solvent was then removed under vacuum. The residue was
washed with cold pentane to yield 7 as an orange powder (147 mg,
1
83%). H NMR (CD2Cl2, 400 MHz): δ 2.90 (m, 2H), 2.64 (m, 4H),
1.82 (m, 6H), 1.72 (m, 2H), 1.65 (m, 2H), 1.53 (m, 2H), 1.47 (d,
J1H‑31P = 1.6 Hz, 15H), 1.35 (m, 14H), 0.88 (m, 3H). 13C{1H} NMR
(CD2Cl2, 100 MHz): δ 216.9 (d, J13C‑31P = 12.8 Hz), 92.2 (d, J13C‑31P
=
2.1 Hz), 44.7 (d, J13C‑31P = 31.4 Hz), 37.8, 37.6, 32.0, 31.9, 29.9, 29.1,
28.5, 28.4, 28.3, 28.2, 26.7, 22.8 (d, J13C‑31P = 5.5 Hz), 14.2, 8.5. 31P
NMR (CD2Cl2, 160 MHz): δ 18.3. IR (cm−1): 1670 (CO).
HRMS(ESI): calcd for [M − 2Cl + H]+ 639.3303, found 639.3301.
Anal. Calcd for C29H50Cl2IrOP: C, 49.14; H, 7.11. Found: C, 49.27; H,
6.97.
[Cp*Ir(iPr2P{(Z)-1-(diisopropylphosphino)hexadec-3-en-1-
one})H]PF6 (13). Silver hexafluorophosphate (75 mg, 0.29 mmol) and
9 (75 mg, 0.099 mmol) were combined in CH2Cl2 (1 mL) and stirred
at 40 °C for 8 h. The mixture was then cooled to ambient temperature
and filtered through a pad of Celite. The resulting solution was
concentrated to ∼0.5 mL, and pentane was added to precipitate a
white powder, which was collected by vacuum filtration and dried in
vacuo to yield 13 (50 mg, 61%). 1H NMR (CDCl3, 400 MHz): δ 3.41
(t, J = 8.4 Hz, 1H, CHCH), 3.10 (m, 1H, CHCH), 2.85 (dd, J =
19.4 Hz, J = 8.8 Hz, 1H, αCH2), 2.46 (q, J = 6.8 Hz, 2H, iPrCH), 2.06
(s, 15H), 2.06 (m, 1H, αCH2), 1.79 (m, 1H, δCH2), 1.43 (m, 2H),
1.25 (m, 24H, CH2 + CH3), 1.00 (dd, J1H‑31P = 17.2 Hz, J = 6.8 Hz,
3H), 0.88 (m, 3H), 0.90 (m, 3H), 0.58 (dd, J1H‑31P = 18.4 Hz, J = 6.4
Hz), 3H), −17.2 (d, J1H‑31P = 32 Hz). 13C{1H} NMR (CDCl3, 100
MHz): δ 225.6 (d, J13C‑31P = 17.2 Hz), 101.2, 58.6 (CHCH), 42.4
(CHCH), 40.4 (d, J13C‑31P = 47.6 Hz, αCH2), 34.5, 32.0, 31.4, 29.7,
29.6, 29.6, 29.5, 29.4, 29.3, 23.4 (d, J13C‑31P = 21.3 Hz), 22.8, 22.5 (d,
J13C‑31P = 35.4 Hz), 18.7, 18.2, 16.6, 16.5, 14.2, 9.9. 31P NMR (CD2Cl2,
160 MHz): δ 72.4 (d, J31P‑1H = 5.3 Hz), −143.8 (sept, J31P‑19F = 712
Hz). 19F NMR (CDCl3, 376 MHz): δ −73.3 (d, J19F‑31P = 712 Hz). IR
(cm−1): 2188 (Ir−H), 1700 (CO). HRMS(ESI): calcd for [M −
PF6]+ 683.3929, found 683.3924.
[Cp*Ir(iPr2P{heptanoyl})Cl2] (8). To a stirring suspension of
[Cp*IrCl2]2 (825 mg, 1.04 mmol) in THF (15 mL) was added 3 (500
mg, 2.17 mmol). The mixture was stirred at ambient temperature for 2
h, and the solvent was then removed under vacuum. The residue was
washed with cold pentane to yield 8 as an orange powder (1.29 g,
1
i
97%). H NMR (C6D6, 400 MHz): δ 3.14 (m, 2H, PrH), 3.05 (m,
2H, αCH2), 1.67 (quint, J = 7.2 Hz, 2H), 1.56 (d, J = 7.2 Hz, 3H), 1.52
(d, J = 7.2 Hz, 3H), 1.27 (m, 4H), 1.23 (d, J1H‑31P = 1.6 Hz, 15H), 1.19
(d, J = 7.2 Hz, 3H), 1.16 (d, J = 7.2 Hz, 3H), 0.87 (t, J = 6.8 Hz, 3H).
13C{1H} NMR (CD2Cl2, 100 MHz): δ 216.8 (d, J13C‑31P = 12.7 Hz)
92.3 (d, J13C‑31P = 2 Hz), 44.9 (d, J13C‑31P = 13.2 Hz, αCH2), 32.0, 29.0,
26.5 (d, J13C‑31P = 24 Hz), 22.8, 21.7, 21.6, 20.0, 14.1, 8.4. 31P NMR
(CD2Cl2, 160 MHz): δ 25.8. IR (cm−1): 1670 (CO). HRMS(ESI):
calcd for [M − 2Cl + H]+ 559.2676, found 559.2658. Anal. Calcd for
C23H42Cl2IrOP: C, 43.94; H, 6.73. Found: C, 44.01; H, 6.70.
[Cp*Ir(iPr2P{palmitoyl})Cl2] (9). To a stirring suspension of
[Cp*IrCl2]2 (150 mg, 0.188 mmol) in THF (5 mL) was added 4 (140
mg, 0.393 mmol). The mixture was stirred at ambient temperature for
2 h, and the solvent was then removed under vacuum. The residue was
6129
dx.doi.org/10.1021/om300471h | Organometallics 2012, 31, 6124−6130